• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
153.9158541
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
22.84
3865.28
EPS(TTM)
Face Value()
Div & Yield %
18.54
10
0.47
 

Ashika Credit Capital reports consolidated net loss of Rs 35.09 crore in the March 2026 quarter
May 18,2026
Net Loss of Ashika Credit Capital reported to Rs 35.09 crore in the quarter ended March 2026 as against net loss of Rs 46.72 crore during the previous quarter ended March 2025. Sales rose 13.99% to Rs 49.79 crore in the quarter ended March 2026 as against Rs 43.68 crore during the previous quarter ended March 2025.

For the full year,net profit declined 20.40% to Rs 60.28 crore in the year ended March 2026 as against Rs 75.73 crore during the previous year ended March 2025. Sales rose 5.70% to Rs 240.05 crore in the year ended March 2026 as against Rs 227.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales49.7943.68 14 240.05227.10 6
OPM %-35.95-123.44 -53.2163.39 -
PBDT-16.96-63.36 73 109.17105.70 3
PBT-21.50-67.06 68 92.0696.99 -5
NP-35.09-46.72 25 60.2875.73 -20